Center for Biologics Evaluation and Research(CBER)
CBER is the FDA center responsible for regulating vaccines, blood products, and certain cellular and gene therapy products.
Usage Examples
- The sponsor engaged CBER for pre-BLA scientific advice on potency assays.
- CBER requested additional comparability data during review.
- The biologics team aligned release testing with CBER expectations.
What is CBER?
The Center for Biologics Evaluation and Research (CBER) oversees biologic products where biological complexity and donor or source controls are central to safety and quality. CBER reviews development programs and marketing applications, inspects manufacturing controls, and manages postmarket safety oversight for products in its jurisdiction.
Regulatory Context
This term appears most often in submission & approval workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 600, 21 CFR 601, 42 USC 262.
When This Matters
- The sponsor engaged CBER for pre-BLA scientific advice on potency assays.
- CBER requested additional comparability data during review.
- The biologics team aligned release testing with CBER expectations.
Common Mistakes
- Treating submission readiness as a formatting-only check without lifecycle validation.
- Using outdated guidance references across modules and summaries.
- Missing cross-functional review between RA, CMC, and quality before submission.
Related Regulations
Frequently Asked Questions
CBER regulates products such as vaccines, blood and blood components, allergenics, and certain cellular and gene therapies.
CBER focuses on specific biologics, while CDER regulates traditional drugs and many therapeutic biologics assigned to CDER.
Yes. CBER monitors safety and quality signals and can require postmarketing actions when needed.
Related Terms
Related Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
Track ICH quality guidelines automatically and get alerts when changes impact your products
Related Regulatory Intelligence
Related Actions
Sources & References
